Nanosecond pulsed electric fields induce the integrated stress response via reactive oxygen species-mediated heme-regulated inhibitor (HRI) activation.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      The integrated stress response (ISR) is one of the most important cytoprotective mechanisms and is integrated by phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF2α). Four eIF2α kinases, heme-regulated inhibitor (HRI), double-stranded RNA-dependent protein kinase (PKR), PKR-like endoplasmic reticulum kinase (PERK), and general control nonderepressible 2 (GCN2), are activated in response to several stress conditions. We previously reported that nanosecond pulsed electric fields (nsPEFs) are a potential therapeutic tool for ISR activation. In this study, we examined which eIF2α kinase is activated by nsPEF treatment. To assess the responsible eIF2α kinase, we used previously established eIF2α kinase quadruple knockout (4KO) and single eIF2α kinase-rescued 4KO mouse embryonic fibroblast (MEF) cells. nsPEFs 70 ns in duration with 30 kV/cm electric fields caused eIF2α phosphorylation in wild-type (WT) MEF cells. On the other hand, nsPEF-induced eIF2α phosphorylation was completely abolished in 4KO MEF cells and was recovered by HRI overexpression. CM-H2DCFDA staining showed that nsPEFs generated reactive oxygen species (ROS), which activated HRI. nsPEF-induced eIF2α phosphorylation was blocked by treatment with the ROS scavenger N-acetyl-L-cysteine (NAC). Our results indicate that the eIF2α kinase HRI is responsible for nsPEF-induced ISR activation and is activated by nsPEF-generated ROS.
      Competing Interests: The authors have declared that no competing interests exist.
    • References:
      Bioelectromagnetics. 2012 Apr;33(3):257-64. (PMID: 21953203)
      Biochem Biophys Res Commun. 2012 Aug 3;424(3):446-50. (PMID: 22771794)
      Mol Metab. 2017 Jul 12;6(9):1024-1039. (PMID: 28951826)
      J Biol Chem. 1998 Nov 27;273(48):32340-6. (PMID: 9822714)
      Sci Rep. 2016 Sep 16;6:32886. (PMID: 27633668)
      Arch Biochem Biophys. 2012 Nov 1;527(1):55-64. (PMID: 22910297)
      Biochem J. 2009 Jan 1;417(1):1-13. (PMID: 19061483)
      Int J Cancer. 2009 Jul 15;125(2):438-45. (PMID: 19408306)
      Exp Cell Res. 2012 Aug 15;318(14):1733-44. (PMID: 22652449)
      Stem Cell Res Ther. 2019 Jan 24;10(1):45. (PMID: 30678730)
      Biochem Biophys Res Commun. 2013 Jun 14;435(4):580-5. (PMID: 23680664)
      J Clin Transl Hepatol. 2018 Mar 28;6(1):85-88. (PMID: 29577034)
      J Cell Physiol. 2018 Feb;233(2):1179-1190. (PMID: 28467607)
      Brain. 2019 Feb 1;142(2):344-361. (PMID: 30657878)
      Bioelectrochemistry. 2012 Oct;87:236-43. (PMID: 22475953)
      Int J Cancer. 2013 Apr 15;132(8):1933-9. (PMID: 23001643)
      J Pharmacol Exp Ther. 2009 Mar;328(3):866-72. (PMID: 19066342)
      Bioelectromagnetics. 2012 Feb;33(2):106-23. (PMID: 21812011)
      EMBO Rep. 2016 Oct;17(10):1374-1395. (PMID: 27629041)
      J Cell Biol. 2004 Oct 11;167(1):27-33. (PMID: 15479734)
      Mol Cell. 2003 Mar;11(3):619-33. (PMID: 12667446)
      Mol Biol Cell. 2005 Dec;16(12):5493-501. (PMID: 16176978)
      Biochem Biophys Res Commun. 2012 May 18;421(4):808-12. (PMID: 22554515)
      PLoS One. 2018 May 1;13(5):e0196688. (PMID: 29715270)
      Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11269-74. (PMID: 15277680)
      Hum Mol Genet. 2014 May 15;23(10):2629-38. (PMID: 24368417)
      Sci Rep. 2018 May 29;8(1):8233. (PMID: 29844431)
      PLoS One. 2012;7(1):e28568. (PMID: 22253692)
      J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):64-8. (PMID: 21068672)
      Apoptosis. 2011 Apr;16(4):382-93. (PMID: 21213047)
      Biochem Biophys Res Commun. 2017 Jan 15;482(3):450-453. (PMID: 28212730)
      J Clin Invest. 2005 Jun;115(6):1562-70. (PMID: 15931390)
      Mutat Res. 2003 Dec 9;542(1-2):65-75. (PMID: 14644355)
      Nat Chem Biol. 2011 Jul 17;7(9):610-6. (PMID: 21765405)
      Science. 2009 Jun 5;324(5932):1334-8. (PMID: 19498172)
      Int J Nanomedicine. 2013;8:3401-4. (PMID: 24039422)
      Blood. 2012 May 31;119(22):5276-84. (PMID: 22498744)
      Expert Opin Ther Targets. 2017 Dec;21(12):1171-1177. (PMID: 29063813)
      Sci Rep. 2017 Sep 5;7(1):10453. (PMID: 28874684)
      Nature. 2016 Mar 24;531(7595):523-527. (PMID: 26982722)
    • Accession Number:
      0 (Reactive Oxygen Species)
      EC 2.7.11.1 (Eif2ak4 protein, mouse)
      EC 2.7.11.1 (PERK kinase)
      EC 2.7.11.1 (Protein Serine-Threonine Kinases)
      EC 2.7.11.1 (eIF-2 Kinase)
      EC 2.7.11.1 (eIF2alpha kinase, mouse)
      EC 2.7.11.1 (protein kinase R, mouse)
      WYQ7N0BPYC (Acetylcysteine)
    • Publication Date:
      Date Created: 20200311 Date Completed: 20200619 Latest Revision: 20211204
    • Publication Date:
      20240105
    • Accession Number:
      PMC7064201
    • Accession Number:
      10.1371/journal.pone.0229948
    • Accession Number:
      32155190